Annamaria Offidani Selected Research

guselkumab

12/2022

Real-world outcomes in patients with moderate-to-severe plaque psoriasis treated with guselkumab for up to 1 year.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Annamaria Offidani Research Topics

Disease

45	Psoriasis (Pustulosis Palmaris et Plantaris) 04/2024 - 01/2015
21	Hidradenitis Suppurativa 05/2024 - 03/2017
19	Infections 01/2023 - 03/2013
15	Neoplasms (Cancer) 03/2024 - 11/2002
14	Melanoma (Melanoma, Malignant) 08/2023 - 11/2002
11	Skin Diseases (Skin Disease) 05/2023 - 02/2018
10	Hyperhidrosis 11/2023 - 01/2003
9	Wounds and Injuries (Trauma) 11/2021 - 01/2008
8	Atopic Dermatitis (Atopic Eczema) 05/2023 - 01/2021
8	COVID-19 04/2022 - 11/2020
6	Inflammation (Inflammations) 05/2023 - 03/2015
6	Wound Infection (Wound Infections) 10/2021 - 01/2008
5	Skin Neoplasms (Skin Cancer) 05/2023 - 12/2019
5	Hypersensitivity (Allergy) 12/2022 - 03/2021
4	Neoplasm Metastasis (Metastasis) 01/2023 - 04/2015
4	Cutaneous Malignant Melanoma 01/2023 - 06/2015
4	Burns 07/2022 - 01/2012
4	Surgical Wound 07/2022 - 04/2008
4	Actinic Keratosis 11/2021 - 01/2016
4	Sepsis (Septicemia) 09/2019 - 01/2016
3	Obesity 04/2024 - 07/2015
3	Psoriatic Arthritis 09/2023 - 01/2018
3	Pigmented Nevus (Melanocytic Nevus) 01/2023 - 11/2002
3	Chronic Urticaria 04/2021 - 01/2021
3	Cicatrix (Scar) 03/2021 - 01/2017
3	Nevus (Nevi) 01/2018 - 11/2002
3	Necrosis 09/2016 - 11/2014
3	Staphylococcal Infections 01/2016 - 06/2008
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 05/2023 - 11/2021
2	Atherosclerosis 01/2023 - 07/2015
2	Pain (Aches) 11/2022 - 01/2022
2	Bronchiolitis Obliterans Syndrome 09/2022 - 06/2021
2	Fibrosis (Cirrhosis) 09/2022 - 03/2015
2	Eczema 02/2022 - 07/2021
2	Squamous Cell Carcinoma of Head and Neck 10/2021 - 06/2021
2	Mycosis Fungoides 07/2021 - 01/2016
2	Keloid 01/2021 - 09/2010
2	Hypertrophic Cicatrix (Hypertrophic Scar) 01/2021 - 09/2010
2	Urticaria (Hives) 01/2021 - 01/2021
2	Ulcerative Colitis 09/2020 - 01/2018
2	Oral Lichen Planus 02/2020 - 12/2015

Drug/Important Bio-Agent (IBA)

14	Biomarkers (Surrogate Marker)IBA 03/2024 - 06/2015
12	Adalimumab (Humira)FDA Link 10/2022 - 03/2016
10	secukinumabIBA 03/2024 - 01/2017
9	Anti-Bacterial Agents (Antibiotics)IBA 05/2023 - 06/2008
8	Nicotinamide N-MethyltransferaseIBA 03/2024 - 01/2018
7	Interleukin-17 (Interleukin 17)IBA 04/2024 - 06/2015
7	EnzymesIBA 03/2024 - 01/2018
7	CytokinesIBA 01/2023 - 01/2017
7	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2021 - 11/2002
6	Botulinum Toxins (Botulinum Toxin)IBA 11/2023 - 01/2003
5	InterleukinsIBA 04/2024 - 03/2016
5	N-nitroso-N-methyltyramine (NNMT)IBA 03/2024 - 01/2018
5	dupilumabIBA 01/2023 - 06/2021
5	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2022 - 07/2015
5	Infliximab (Remicade)FDA Link 02/2022 - 01/2016
5	Etanercept (Enbrel)FDA Link 02/2022 - 09/2016
5	Type A Botulinum Toxins (Botox)FDA Link 01/2022 - 01/2003
5	Tigecycline (Tygacil)FDA Link 01/2018 - 01/2012
4	VaccinesIBA 08/2023 - 04/2021
4	Monoclonal AntibodiesIBA 01/2023 - 01/2017
4	dalbavancinIBA 11/2022 - 01/2020
4	Aryldialkylphosphatase (Paraoxonase)IBA 11/2021 - 01/2020
4	Interleukin-23 (Interleukin 23)IBA 04/2021 - 06/2015
4	TeicoplaninIBA 12/2016 - 01/2008
3	bimekizumabIBA 04/2024 - 01/2023
3	Messenger RNA (mRNA)IBA 03/2024 - 10/2020
3	AdipokinesIBA 01/2023 - 07/2015
3	oxybutynin (Tavor)FDA LinkGeneric 01/2023 - 03/2015
3	Immunosuppressive Agents (Immunosuppressants)IBA 11/2022 - 09/2019
3	Daptomycin FDA Link 07/2022 - 12/2016
3	Ustekinumab (CNTO 1275)FDA Link 02/2022 - 01/2017
3	ixekizumabIBA 09/2021 - 01/2017
3	Omalizumab (Xolair)FDA Link 04/2021 - 01/2021
3	AllantoinIBA 01/2021 - 09/2010
3	SteroidsIBA 06/2020 - 01/2014
3	Matrix Metalloproteinase 9 (Gelatinase B)IBA 06/2013 - 11/2002
2	RetinoidsIBA 05/2024 - 09/2019
2	MicroRNAs (MicroRNA)IBA 06/2023 - 05/2023
2	Antimicrobial PeptidesIBA 12/2022 - 01/2018
2	Biosimilar PharmaceuticalsIBA 10/2022 - 01/2020
2	Cholinergic Antagonists (Anticholinergics)IBA 01/2022 - 03/2015
2	apremilastIBA 11/2021 - 01/2021
2	4-amino-4'-hydroxylaminodiphenylsulfone (HADS)IBA 11/2021 - 01/2021
2	Dacarbazine (DIC)FDA LinkGeneric 11/2021 - 12/2020
2	CollagenIBA 10/2021 - 06/2013
2	Niacinamide (Nicotinamide)FDA LinkGeneric 09/2021 - 08/2020
2	Interleukin-12 (IL 12)IBA 04/2021 - 01/2017
2	calcipotriene (calcipotriol)FDA LinkGeneric 01/2021 - 06/2020
2	NeurotoxinsIBA 01/2021 - 03/2017
2	Antirheumatic Agents (DMARD)IBA 04/2020 - 11/2019
2	AntioxidantsIBA 01/2020 - 01/2019
2	golimumab FDA Link 11/2019 - 01/2019

Therapy/Procedure

41	Therapeutics 03/2024 - 06/2008
11	Biological Therapy 10/2022 - 01/2017
3	Aftercare (After-Treatment) 11/2021 - 01/2003
3	Phototherapy (Light Therapy) 01/2021 - 11/2010
2	Immunomodulation 04/2022 - 11/2020
2	Contraindications 07/2021 - 04/2021
2	Immunotherapy 06/2020 - 01/2018